Drug Topics
JANUARY 25, 2024
A study found that patients with type 2 diabetes who showed evidence of any remission had a 33% lower rate of chronic kidney disease, and a 40% lower rate of the composite cardiovascular disease measure.
STAT
JANUARY 25, 2024
A historic new study out of Scotland shows the real-world impact of vaccines against the human papillomavirus: The country has detected no cases of cervical cancer in women born between 1988-1996 who were fully vaccinated against HPV between the ages of 12 and 13. Many previous studies have shown that HPV vaccines are extremely effective in preventing cervical cancer.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JANUARY 25, 2024
Eosinophilic esophagitis is a chronic, progressive disease thought to be responsible for damaging the esophagus, and it can severely impact a child’s ability to eat.
STAT
JANUARY 25, 2024
WASHINGTON — Sen. Bernie Sanders on Thursday jabbed the CEO of Merck for telling congressional staff that he didn’t have the expertise to testify at a Senate hearing on prescription drug prices because he’s a tax attorney. Sanders, who has threatened to subpoena the CEOs of Merck and Johnson & Johnson over their refusal to testify at a hearing on why drug prices are higher in the United States than other countries, told reporters the reasons the companies gave ranged fro
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacy Times
JANUARY 25, 2024
Treating older patients requires a greater focus on treating their AD without exacerbating their comorbidities.
STAT
JANUARY 25, 2024
Transgender women, in particular those belonging to marginalized racial and ethnic groups, have disproportionately high rates of HIV. Yet so far, no standardized surveillance system has collected data that could provide insight into the factors that put people at higher risk for contracting the virus. A survey of transgender women, developed by the Centers for Disease Control and Prevention, aimed to gather and assess behavioral data in relation to HIV prevention and risk for the first time.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
JANUARY 25, 2024
Limor Appelbaum has seen too many patients whose first sign of a fatal illness came too late. Often it’s yellowed eyes from jaundice, caused by a cancerous tumor on the pancreas that has grown so large it presses against the bile duct system. By this point, little can be done. “All we can really offer them is something that can prolong life by a few months,” and comfort care, said Appelbaum, a staff scientist at Beth Israel Deaconess Medical Center.
Pharmacy Times
JANUARY 25, 2024
The approval marks dupilumab as the first and only FDA-approved medicine to treat pediatric patients with eosinophilic esophagitis.
STAT
JANUARY 25, 2024
LONDON — Two research centers that have been at the forefront of following the evolution of the SARS-CoV-2 coronavirus — one in the U.K. and one in South Africa — have teamed up on a partnership that they say will expand their efforts to track emerging disease threats around the world. The collaboration between the U.K.’s Wellcome Sanger Institute and South Africa’s Centre for Epidemic Response and Innovation, announced Thursday, comes as much of the infrastruc
Fierce Healthcare
JANUARY 25, 2024
Humana primed the pump last week for a disappointing fourth quarter call, and its stock again dropped Thursday morning as the company posted a $541 million loss. | Humana primed the pump last week for a disappointing fourth quarter call, and its stock again dropped Thursday morning as the company posted a $541 million loss.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
JANUARY 25, 2024
Imagine this scene: You are a cancer patient already navigating fear and uncertainty around your treatment, when you inexplicably cannot access the care recommended by your cancer doctor. This turns out to be because of a perverse hurdle imposed by your insurance company — called a prior authorization — that ends in a denial of care.
Pharmacy Times
JANUARY 25, 2024
Since 2000, as the number of CDIs has surged, morbidity and mortality also have increased.
STAT
JANUARY 25, 2024
Senate Majority Leader Chuck Schumer (D-N.Y.) wants the federal government to investigate Zyn nicotine pouches. Schumer is no stranger to calling for crackdowns on popular products — he’s done similar with Four Loko and Logan Paul’s line of energy drinks. The problem for Schumer this time around is that many users of Zyn are very passionate, and very, very online.
Fierce Healthcare
JANUARY 25, 2024
The U.S. faces a growing shortage of neurologists, creating care "deserts" around the country, forcing patients to wait longer and drive further to receive care. | Digital health company Isaac Health launched in 2022 to provide a virtual brain health and memory clinic platform with the goal of improving access to constrained brain health services.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
JANUARY 25, 2024
CVS Health is perhaps best known for two things. First, there are the comically long receipts that have inspired hundreds of internet memes. And then there’s the ubiquitous presence of its stores. If it seems like there’s a CVS pharmacy on every other block, that’s because the company operates 9,000 stores nationwide, including nearly 500 across Massachusetts.
Pharmacy Times
JANUARY 25, 2024
Gabriella Farkas, MD PhD, addresses the multifaceted role of pharmacists in the mental health and wellness space
Fierce Pharma
JANUARY 25, 2024
Three months after launching an investigation into the risk of patients developing secondary T-cell cancers after receiving a CAR-T drug, the FDA has shared more information on the cases it has see | Three months after launching an investigation into the risk of secondary T-cell cancers after treatment with a CAR-T medicine, the FDA has shared more information on the cases that it has seen.
Fierce Healthcare
JANUARY 25, 2024
The Centers for Medicare & Medicaid Services is seeking feedback on how to increase transparency around Medicare Advantage and improve data capabilities. | CMS initiated a request for information period Thursday to receive data on all aspects of the Medicare Advantage program including prior authorizations, value-based care and vertical integration.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
JANUARY 25, 2024
Creating additional space for nursing mothers can be challenging in small pharmacies
STAT
JANUARY 25, 2024
Humana’s Medicare Advantage business is faring even worse than the company let on last week , with “unprecedented” numbers of older adults getting medical care and busting through its tactics for holding up payment. The country’s second largest private Medicare insurer disclosed Thursday it’s projecting roughly half the profit in 2024 that investors had expected.
Fierce Healthcare
JANUARY 25, 2024
As Amazon builds out its healthcare business and expands its reach into hybrid primary care, pharmacy operations and virtual care, there are promising opportunities to integrate these services to o | A year after its big-ticket primary care acquisition, Amazon Pharmacy is piloting a program to provide pharmacy consultations to One Medical providers with a specific focus on high-risk and complex patients among the older senior population.
STAT
JANUARY 25, 2024
The federal government is suing to block a proposed hospital deal in North Carolina, alleging it would hand control of over 65% of the inpatient market in the region to a single provider. Novant Health’s proposed acquisition of two nearby hospitals is precisely the kind of case antitrust experts would expect the Federal Trade Commission to take on because it would make an already large regional player , Novant, even more powerful.
Pharmacy Times
JANUARY 25, 2024
Tune in to this special episode for an exclusive insight into the future of health technology and wearable innovation, including a glimpse into the world of CES 2024.
STAT
JANUARY 25, 2024
WASHINGTON — For an app that helps pharmacies in Africa manage their medicines, the term “pharmacy benefit manager” has become a dirty word. The organization, called Maisha Meds, plays the role of a middleman between international groups like USAID and the Gates Foundation and pharmacies. By definition, it’s a PBM. But since it’s a nonprofit company and it subsidizes medicines and tests aimed at promoting public health, it’s hesitant to describe itself t
Fierce Healthcare
JANUARY 25, 2024
Four in five clinicians believe it’s important for their hospital to address climate change and that doing so is aligned with their organization’s mission, a new
STAT
JANUARY 25, 2024
WASHINGTON — A key Senate committee is proposing that Medicare pay bonuses to hospitals that take measures to prevent drug shortages. It also wants to change the way doctors are paid to administer drugs in outpatient settings. After a startling number of drugs, including chemotherapies, were in shortage last year, Washington stepped up its efforts to find policy solutions for the problems.
Fierce Healthcare
JANUARY 25, 2024
Below is a round-up of payer-centric news for the week of Jan. 22, 2024 | This week, California health plans formed a coalition to address long-term PPE shortages, Mark Cuban's drug company announced a new partnership with Livinity, popularity rises for Colorado's public option plans and more.
STAT
JANUARY 25, 2024
Over the last year or two, something curious has started occurring in the conference rooms and private Zoom meetings of biotech venture capitalists. Representatives from pension funds, college endowments, family offices, and other organizations with money to invest have become bolder in their requests, according to interviews with a host of VCs. They’re pushing not only for advantageous terms in a VC firm’s latest fund, but in some cases, have angled for equity in the firm itself.
Drug Store News
JANUARY 25, 2024
The Pharmacy 50 program, launched in 2021 by The Pharmacy Podcast Network, is recognizing individuals that have had a significant impact on the accomplishments of others in pharmacy.
STAT
JANUARY 25, 2024
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. Bernie’s subpoena showdown We’re less than a week away from a scheduled vote on subpoenaing the CEOs of two drugmakers, J&J and Merck.
Fierce Healthcare
JANUARY 25, 2024
2023 was the biggest year for healthcare Chapter 11 bankruptcy filings in the past half-decade, according to a new research report from Gibbins Advisors. | There were 79 bankruptcy filings across healthcare-related sectors last year, 12 of which were hospitals. Those are both up from 2022's 46 total and two hospital filings, according to a new report.
STAT
JANUARY 25, 2024
The trade group for generic drug companies in the U.S. has filed a lawsuit alleging a new Illinois law that is designed to prevent price gouging is unconstitutional, the latest effort to push back against states attempting to lower the cost of medicines. In its lawsuit, the Association for Accessible Medicines argued the law gives the state the power to regulate interstate commerce.
pharmaphorum
JANUARY 25, 2024
Discover the role of GenAI in life sciences in 2024. Explore how artificial intelligence and machine learning techniques like GenAI are revolutionising drug development, diagnostics, and research. Learn how industry leaders, including Google, are leveraging GenAI to advance healthcare and enhance patient outcomes.
Expert insights. Personalized for you.
210 
Let's personalize your content